Bone Density in Voluntary Apheresis Blood Donors
Completed · Not applicable
Conditions studied: Bone Density
In brief
A longitudinal, randomized, controlled, single-center Phase IV clinical trial will be performed to assess changes in bone mineral density (BMD) among voluntary apheresis blood donors. The primary outcome measure will be clinically significant decline in BMD at the lumbar spine assessed by dual-energy x-ray absorptiometry (DXA).
Key facts
- Study ID
- NCT02655055
- Run by
- Versiti Blood Health
- People needed
- 58
- Starts
- 2016-05-01
- Expected to finish
- 2018-04-01
- Last updated by the study team
- 2022-03-09
Who can join
Age: 18 and older, up to 65. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- male
- eligible volunteer blood donor
- ≥ 18, and, ≤ 65 years of age at enrollment
- ≥ 1, and, ≤ 5 prior apheresis blood donation procedures
You may not qualify if…
- female
- age < 18 or > 65 years at enrollment
- ineligible for whole blood donation
- BMD Z-score <(-2.0) or >(2.0) at any measurement site upon baseline assessment
- metal prosthesis at measurement site
- weight > 300 lbs (136 kg)
- previous fracture of the lumbar spine or femoral neck
- any fragility fracture, defined as a fracture resulting from a fall of standing height or less, during adulthood (specifically ≥18 years of age at the time of fracture)
- previous lumbar spinal fusion surgery
- cystic fibrosis
- emphysema
- celiac disease
- Crohn's disease
- Current or past (>1 month duration) use of medications known to affect BMD including, not limited to: (phenytoin, phenobarbital, corticosteroids)
- Current Osteoporosis Medication use including, but not limited to: (Forteo, oral biphosphonates, Reclast, Prolia, calcitonin)
- Unable or unwilling to donate high frequency apheresis
Where it is running
- BloodCenter of Wisconsin — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.